About South Jersey Gastroenterology
Clinical Trials at South Jersey Gastroenterology
During the past decade, South Jersey Gastroenterology conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 6 clinical trials were completed, i.e. on
average, 600% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "South Jersey Gastroenterology" #1 sponsor was "Pfizer" with 3 trials, followed by "Shire" with 2 trials
sponsored, "Braintree Laboratories" with 1 trials sponsored, "Forest Laboratories" with 1 trials sponsored and "James Lewis"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "South Jersey Gastroenterology"
#1 collaborator was "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 1 trials as a collaborator, "RTI Health Solutions" with 1 trials as a collaborator and "Shire" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at South Jersey Gastroenterology
According to Clinical.Site data, the most researched conditions in "South Jersey Gastroenterology" are
"Ulcerative Colitis" (4 trials), "Diarrhea Predominant Irritable Bowel Syndrome" (1 trials), "Diverticulitis" (1 trials), "Eosinophilic Esophagitis (EoE)" (1 trials) and "Perianal Crohn's Disease" (1 trials). Many other conditions were trialed in "South Jersey Gastroenterology" in a lesser frequency.
Clinical Trials Intervention Types at South Jersey Gastroenterology
Most popular intervention types in "South Jersey Gastroenterology" are "Drug" (9 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "CP-690,550" (2 trials), "Asimadoline" (1 trials), "BLI-1300 high dose" (1 trials) and "BLI-1300 low dose" (1 trials). Other intervention names were less common.
Clinical Trials Genders at South Jersey Gastroenterology
The vast majority of trials in "South Jersey Gastroenterology" are
9 trials for "All" genders.
Clinical Trials Status at South Jersey Gastroenterology
Currently, there are NaN active trials in "South Jersey Gastroenterology".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in South Jersey Gastroenterology,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in South Jersey Gastroenterology, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".